Main content
Wegovy maker, Novo Nordisk, warns of price squeeze
Shares in the Danish drugmaker behind Ozempic and Wegovy fell sharply after its boss warned price cuts will hurt before any recovery.
The maker of Ozempic says tougher competition from generics in India and China will hit profits this year. Leanna Byrne speaks to its chief financial officer.
Plus, Spain moves closer to banning social media for under-16s.
And the United States renews a trade deal giving 32 African countries duty-free access to its market.
More episodes
Podcast
![]()
World Business Report
The latest business and finance news from around the world, on the BBC.
